-
Talita H. Ferreira-Vieira, Isabella M. Guimaraes, Flavia R. Silva, and Fabiola M. Ribeiro . Alzheimer's Disease: Targeting the Cholinergic System. Curr Neuropharmacol. 2016 Jan; 14(1): 101–115. doi: 10.2174/1570159X13666150716165726
-
Mark W. Bondi, Emily C. Edmonds, David P. Salmon. Alzheimer’s Disease: Past, Present, and Future. J Int Neuropsychol Soc. 2017 Oct; 23(9-10): 818–831. doi: 10.1017/S135561771700100X
-
Dawkins, E. Small, D.H. Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer’s disease. J. Neurochem. 2014, 129, 756–769. https://doi.org/10.1111/jnc.12675
-
Zhang, Z. Song, M. Liu, X. Su Kang, S. Duong, D.M. Seyfried, N.T. Cao, X.; Cheng, L. Sun, Y.E. Ping Yu, S. et al. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease. Nat. Commun. 2015, 6, 8762. doi: 10.1038/ncomms9762.
-
Macchi B, Marino-Merlo F, Frezza C, Cuzzocrea S, Mastino A. Inflammation and programmed cell death in Alzheimer's disease: comparison of the central nervous system and peripheral blood. Mol Neurobiol., 2014;50:463-72. DOI: 10.1007/s12035-014-8641-9
-
Boutajangout A, Wisniewski T. Tau-based therapeutic approaches for Alzheimer's disease - a mini-review. Gerontology. 2014; 60:381-385. https://doi.org/10.1159/000358875
-
Filley CM. Alzheimer's disease in women. Am J Obstet Gynecol. 1997;176:1-7. doi: 10.1016/s0002-9378(97)80003-8.
-
2020 Alzheimer's disease facts and figures. [ALZHEIMER'S ASSOCIATION REPORT]. Alzheimer's Association: 10 March 2020 https://doi.org/10.1002/alz.12068
-
Liu Z, Zhang A, Sun H. Two decades of new drug discovery and development for Alzheimer's disease. RSC Adv. 2017;7(10):6046–6058. DOI: 10.1039/C6RA26737H.
-
Thakur AK, Kamboj P, Goswami K. Pathophysiology and management of Alzheimer's disease: an overview. J Anal Pharm Res. 2018;9(2):226-235. DOI: 10.15406/japlr.2018.07.00230.
-
Thies, W. Bleiler, L. Alzheimer’s Association Report: 2013 Alzheimer’s Disease Facts and Figures. Alzheimer Dement.2013, 9, 208–245.
-
Schaffer C, Sarad N, DeCrumpe A, Goswami D, Herrmann S, Morales J, Patel P, Osborne J. Biomarkers in the Diagnosis and Prognosis of Alzheimer’s Disease. J Lab Autom. 2015, 2014 Society for Laboratory Automation and Screening. doi: 10.1177/2211068214559979.
-
Scheuner A, D Eckman, Jensen C, Secreted Amyloid Beta-Protein Similar to That in the Senile Plaques of Alzheimer’s Disease Is Increased In Vivo by the Presenilin 1 and 2 and APP Mutations Linked to Familial Alzheimer’s Disease. Nat. Med. 1996, 2, 864–870. DOI: 10.1038/nm0896-864
-
Jesus A, Jose J L, Mar P, Felix H. Role of tau protein in both physiological and pathological conditions. Physiol Rev. 2004 Apr;84(2):361-84. doi: 10.1152/physrev.00024.2003.
-
Shah, K. DeSilva, S. Abbruscato, T. The Role of Glucose Transporters in Brain Disease: Diabetes and Alzheimer’s Disease. Int J Mol Sci. 2012, 13, 12629–12655. doi: 10.3390/ijms131012629.
-
Patel, S. Shah, R. J. Coleman, P. Potential Peripheral Biomarkers for the Diagnosis of Alzheimer’s disease. Int J Alzheimer’s Dis. 2011; 2(11):1–9. doi: 10.4061/2011/572495
-
Jack CR, Wiste D, Vemuri P. Brain Beta- Amyloid Measures and Magnetic Resonance Imaging Atrophy Both Predict Time-to-Progression from Mild Cognitive Impairment to Alzheimer’s Disease. Brain 2010,133, 3336–3348. doi: 10.1093/brain/awq277.
-
Meena, A. A Study of Functional Brain Metabolism Using PET Scan Image Datasets: An Analysis. J.Comput. 2013, 6, 28–30.
-
Miners JS, Barua N, Kehoe PG, Gill S, Seth L. Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer Disease. Journal of Neuropathology & Experimental Neurology, Volume 70, Issue 11, November 2011, Pages 944–959, https://doi.org/10.1097/NEN.0b013e3182345e46.
-
Witter S, Witter R, Vilu R, Samosona A. Medical Plants and Nutraceuticals for Amyloid-β Fibrillation Inhibition. J Alzheimers Dis Rep. 2018; 2(1): 239–252. doi: 10.3233/ADR-180066
-
Rammohan V R, Descamps O, John V, Dale EB. Ayurvedic medicinal plants for Alzheimer's disease: a review. Alzheimer's Res Ther. 2012; 4(3): 22.doi: 10.1186/alzrt125
-
Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM. Curcumin inhibits the formation of amyloid-beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005;280:5892–5901. DOI: 10.1074/jbc.M404751200
-
Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001;21:8370–8377. doi: 10.1523/JNEUROSCI.21-21-08370.2001.
-
Shinomol GK, Bharath MM. Exploring the role of 'Brahmi' (Bocopa monnieri and Centella asiatica) in brain function and therapy. Recent Pat Endocr Metab Immune Drug Discov. 2011;5:33–49. doi: 10.2174/187221411794351833.
-
Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology. 2008;9:369–374. doi: 10.1007/s10522-008-9185-z.
-
Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother Res. 2000; 14:174–179. doi: 10.1002/(SICI)1099-1573(200005)14:3<174:AID-PTR624>3.0.CO;2-O.
-
Limpeanchob N, Jaipan S, Rattanakaruna S, Phrompittayarat W, Ingkaninan K. Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture. J Ethnopharmacol. 2008;120:112–117. doi: 10.1016/j.jep.2008.07.039.
-
Cervenka F, Jahodar L. Plant metabolites as nootropics and cognitive. Ceska Slov Farm. 2006;55:219–229. Article in Czech.
-
Dhanasekaran M, Holcomb LA, Hitt AR, Tharakan B, Porter JW, Young KA, Manyam BV. Centella Asiatica extract selectively decreases amyloid-beta levels in the hippocampus of the Alzheimer's disease animal model. Phytother Res. 2009;23:14–19. doi: 10.1002/ptr.2405.
-
Veerendra Kumar MH, Gupta YK. Effect of Centella Asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin Exp Pharmacol Physiol. 2003;30:336–342. doi: 10.1046/j.1440-1681.2003.03842.x.
-
Malik J, Karan M, Vasisht K. Nootropic, anxiolytic and CNS-depressant studies on different plant sources of shankhpushpi. Pharm Biol. 2011;49:1234–1242. doi: 10.3109/13880209.2011.584539.
-
Mukherjee PK, Kumar V, Kumar NS, Heinrich M. The Ayurvedic medicine Clitoria ternatea--from traditional use to scientific assessment. J Ethnopharmacol. 2008;120:291–301. doi: 10.1016/j.jep.2008.09.009.
-
Hao W, Friedman A. Mathematical model on Alzheimer’s disease. BMC Syst Biol. 2016:10(1):108. doi: 10.1186/s12918-016-0348-2.
-
Puri KI, Li L. Mathematical Modeling for the Pathogenesis of Alzheimer's Disease. PLoS ONE 5(12): e15176. https://doi.org/10.1371/journal.pone.0015176
-
Voropaeva OV, Bayadilov OV, Leontiev SV. Mathematical modelling of the dynamics of cell death in aseptic inflammation, in Actual Problems of Applied Mathematics, Computer Science and Mechanics, International Scientific and Technical Conference Proceedings 2017. pp. 625–631.
-
Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017:7:42717. doi: 10.1038/srep42717.